Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NH125
Cat. No.:
OB0225LY-0257
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
NH125 is a selective eEF-2 kinase inhibitor that inhibits histidine kinase.
Synonym:
278603-08-0; 1-Benzyl-3-cetyl-2-methylimidazolium iodide; 3-Benzyl-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide; 1-Hexadecyl-2-methyl-3-(phenylmethyl)-1H-imidazolium iodide
CAS No.:
278603-08-0
Compound CID:
10436839
Formula:
C27H45IN2
Formula Weight:
524.56
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
NH125 t can be used in neurobiology research or play an important role in drug development.
Library Information
Targets:
CaMK family; PKC family; PKA family; Kinases; Viral enzymes
Receptors:
CaMK; CaMKII; eEF-2 kinase; PKA; PKC; Virus protease
Pathways:
Neuronal signaling; Microbiology/Virology; Tyrosine kinase/adaptors; Cytoskeletal signaling; Autophagy; Chromatin/Epigenetic
Plate Number:
AOCL-4
Plate Location:
c3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
52.5 mg/mL; 100 mM
Ethanol Max Solubility:
39.3 mg/mL; 75 mM
